Condor Research, operated by Atrio Sciences s.r.o. in Slovakia, is a European supplier of reference compounds for laboratory research. This page documents how quality is established and verified for every batch we hold. It is informational, not promotional: the goal is to state exactly what testing is performed, what a Certificate of Analysis contains, and where the limits of those data lie. All materials are supplied strictly for research use only (RUO) and in vitro investigation. Nothing here describes or implies suitability for human or veterinary use.
How does Condor Research guarantee quality?
Quality at Condor rests on a single, verifiable principle: every batch is tested by an independent third-party laboratory based in the EU (located in Czechia) before it is offered. We do not rely solely on supplier-provided documentation or on internal testing. The independent lab characterizes each lot, and the resulting data are issued as a per-batch Certificate of Analysis (COA) tied to that specific lot number.
The core analytical methods are:
- HPLC (high-performance liquid chromatography) — used to establish identity and purity. The specification is ≥99% for individual compounds. For combination blends, purity is reported per component rather than as a single aggregate figure, so each constituent is characterized on its own terms.
- Mass spectrometry (MS) — applied to peptides to confirm molecular identity against the expected mass.
Materials are stored in our EU warehouse in Slovakia. Where applicable under REACH, a Safety Data Sheet (SDS) with CLP classification and labelling is provided so that the research buyer has the hazard information needed to handle the material safely in a laboratory setting.
What does the testing process cover?
The table below summarizes each quality criterion, the method behind it, and what it tells a researcher. It is intended to be skimmed and, where useful, cited directly.
| Criterion | Method | What it establishes | Specification / scope |
|---|---|---|---|
| Independent testing | Third-party EU laboratory (Czechia) | Results are not self-reported by the seller or relied upon solely from the supplier | Every batch |
| Identity | HPLC; MS for peptides | Confirms the material is the stated compound | All compounds; MS adds mass confirmation for peptides |
| Purity | HPLC | Quantifies how much of the material is the target compound | ≥99% for individual compounds; per-component for blends |
| Hazard documentation | SDS / CLP under REACH | Provides classification, labelling and safe-handling information | Where applicable |
| Traceability | Per-batch COA with lot number | Links the analytical data to the exact lot you receive | Every batch |
| Storage | EU warehouse (Slovakia) | Material held within the EU | All inventory |
What does a Condor Research Certificate of Analysis (COA) include?
A COA is a lot-specific document issued for the batch you receive. For Condor, a COA reflects the third-party testing described above and typically documents:
- The compound identity, confirmed by HPLC and — for peptides — by mass spectrometry.
- The purity result from HPLC, reported against the ≥99% specification for individual compounds, or per component for blends.
- Mass-spectrometry confirmation for peptides.
- The batch / lot number, so the certificate is traceable to the specific material in hand.
Because the COA is tied to a lot, it is the document a researcher should retain for record-keeping and method validation, rather than a generic product datasheet. Where REACH applies, the SDS is a separate document covering hazard classification and handling.
Why does independent, third-party testing matter?
In the research-compound market, purity claims are common but the basis for them varies widely. The meaningful distinction is not whether a number is printed, but who generated it and against what method. Condor’s position is straightforward: the analytical work is done by an independent EU laboratory, the method is HPLC for purity with MS identity confirmation for peptides, and the result is issued per batch. That combination is what lets a researcher treat the figure as a data point rather than a marketing line.
We state this plainly to avoid overclaiming: a ≥99% HPLC purity specification describes the chromatographic purity of the target compound for that lot under the lab’s method. It is an analytical characterization for laboratory research, not a statement about safety, efficacy, or any use in humans or animals.
Buyer checklist: reading a research-compound COA
Whether you are evaluating Condor or any other supplier, the following checklist helps you judge what a certificate actually demonstrates:
- ☐ Is the testing independent? Look for a named third-party laboratory rather than seller-only or supplier-only data. Condor uses an independent EU lab in Czechia.
- ☐ Is the COA lot-specific? A batch / lot number should tie the data to the exact material. Condor issues a COA per batch.
- ☐ What method produced the purity figure? HPLC is the expected method for purity; Condor specifies ≥99% for individual compounds.
- ☐ For blends, is purity reported per component? A single aggregate number can hide a weak constituent. Condor reports per component.
- ☐ For peptides, is identity confirmed by MS? Mass spectrometry confirms the molecule matches its expected mass. Condor applies MS to peptides.
- ☐ Is hazard documentation available? An SDS with CLP classification under REACH should be provided where applicable.
Where the data are honest about their limits
We try to be precise rather than impressive. SDS/CLP documentation is provided where applicable under REACH — not as a blanket claim across every item. The ≥99% purity specification applies to individual compounds; blends are characterized per component instead of by a single combined figure. HPLC purity and MS identity are analytical measurements for research, and they do not speak to fitness for any human or clinical purpose. Stating these boundaries is itself part of quality: a certificate is only as useful as the accuracy of the claims around it.
Logistics and ordering context
Tested inventory ships from the EU warehouse in Slovakia via Packeta, DPD, or DHL, with free shipping on orders of €150 or more, under DAP (Incoterms 2020). Sales are final B2B transactions (no returns) except where mandatory law requires otherwise. These terms sit alongside the quality program described above; they do not change the RUO framing of the materials.
Explore tested compounds
The quality process described here applies across the catalog. You can review specific products and their categories:
- BPC-157 — a widely referenced peptide in the Peptides in Vials range.
- GLOW (GHK-Cu + BPC-157 + TB-500) — an example from Combination Blends, where purity is reported per component.
- BPC-157 Arginate Capsules — from the Encapsulated Compounds range.
All products supplied by Condor Research (Atrio Sciences s.r.o.) are for research use only / in vitro use. They are not for human or veterinary use, not drugs, foods, or cosmetics, and not for diagnostic or therapeutic purposes.
Frequently asked questions
How does Condor Research guarantee quality?
Every batch is tested by an independent third-party laboratory in the EU (located in Czechia). Identity and purity are determined by HPLC (≥99% for individual compounds; per-component for blends), and peptides are confirmed by mass spectrometry. Each batch ships with a lot-specific Certificate of Analysis.
What does a Condor Research COA include?
A Condor COA is lot-specific and documents the compound identity (HPLC, plus mass spectrometry for peptides), the HPLC purity result against the ≥99% specification (or per component for blends), mass-spectrometry confirmation for peptides, and the batch/lot number for traceability to the exact material received.
Is the testing done in-house or by an independent lab?
Testing is performed by an independent third-party laboratory based in the EU (Czechia), not solely in-house or relied upon only from the supplier. This independence is what lets researchers treat the reported purity and identity data as verifiable analytical results.
What purity standard does Condor Research use?
The specification is ≥99% purity by HPLC for individual compounds. For combination blends, purity is reported per component rather than as a single aggregate figure, so each constituent is characterized on its own. This is an analytical measurement for research use only.
How is purity reported for blends versus single compounds?
Single compounds are characterized against a ≥99% HPLC purity specification. Blends are reported per component, meaning each ingredient in the blend has its own purity figure rather than one combined number that could mask a weaker constituent.
Are Safety Data Sheets always provided?
A Safety Data Sheet (SDS) with CLP classification under REACH is provided where applicable. It is not a blanket claim across every item; it applies where relevant to the specific material, in keeping with honest documentation of what was tested and supplied.